SPOTLIGHT -
Don’t Get Caught Up With a HIPAA Violation
Sometimes, breaches in information are the result of a simple mistake. How can those be avoided?
US Representatives From Ohio, New Hampshire Write Bipartisan Letter to FDA Warning of Potential DSCSA Problems
The act is currently set to go into effect in just over three months.
How Far Should Community Outreach Go for Pharmacies?
How Much Power Should You Give Automation in the Front-End of Your Pharmacy?
The world continues to become more automated, but how much responsibility should you give AI within your pharmacy?
Total Pharmacy Solutions Summit: Expanding Your Pharmacy’s Clinical Capabilities
What are pharmacies capable of, and how do we work to reach those possibilities?
The Effectiveness of Biologics in Preventing Penetrating Complications in Patients With CD
A study presented at Digestive Disease Week 2023 compared the effectiveness of different approaches to prevent complications in individuals with the common disease.
Biosimilar Infliximab Not Shown to Cause Adverse Outcomes in Patients With IBD
Hesitation from patients and providers to switch to an infliximab biosimilar may not be necessary, new study finds.
The Changing Landscape of Digital Health
What does the future of digital health look like?
Contraceptives, Gender-Affirming Care, and Other Hot Topics for Pharmacists
What is the state of OTC contraception, what’s next for IUDs, and why are so many transgender people denied care?
How the Workplace Can Impact Respiratory Health
A recent study examined the effects that different work environments can have on adults with asthma.
Why Are Pharmacogenomics Not Fully Implemented in Health Care?
A look at how the genetics-based research field can become more fully integrated in all areas of health care going forward.
House Energy and Commerce Committee Looks to Reign In PBM Power
The role of pharmacy benefit managers in the health care space is being scrutinized more than ever before.
Should We Welcome AI, Fear It, Or Both?
A research article outlines the future of artificial intelligence in health care.
What Is The Link Between Antidepressants and Hospital-Acquired Clostridium Difficile Infection?
Researchers found an increased occurrence of CDI in individuals who were prescribed antidepressants.
How Biologic Therapy Can Help Mitigate COVID-Related Complications In Patients With IBD
New data from Digestive Disease Week furthers evidence that biologics can be effective
Fourth Dose of COVID Vaccine Produced Milder Symptoms In Patients With IBD
Data presented at Digestive Disease Week show that patients with IBD had less intense post-vaccination symptoms after a fourth dose.
The Challenges Of Keeping Proper Inventory in Pharmacy
Keeping inventory in pharmacy is already difficult. And keeping stock of dangerous substances like opioids requires even more caution.
How Understanding Risk Factors Can Help Patients With Chronic Diseases Quit Smoking
How much does education about the specific risks of smoking assist in smoking cessation?
Hundreds Of Pharma Executives Sign Open Letter Condemning Mifepristone Ruling
Over 400 pharmaceutical employees and executives signed an open letter in a show of solidarity with the FDA, but some say that big pharma’s actions helped lead to this moment in the first place.
Age, Food Security, And Financial Situation All Common Factors in OUD Cases
A new study from JAPHA explores the link between OUD and social factors.
Texas Judge Rules to Suspend Nationwide Distribution of Abortion Drug
The FDA, state governors, and OB/GYN groups around the country are fighting back against Judge Matthew Kacsmaryk’s ruling.
Cytokinetics Announces Discontinuation Of ALS Drug Trial
The biopharmaceutical company says it is “extremely disappointed” with the results of the COURAGE-ALS study, which failed to meet primary or secondary endpoints.
FDA-Approved Konvomep Releases To Public
The drug is a rare FDA-approved liquid formulation that treats ulcers and lowers risk of gastrointestinal bleeding in chronically ill patients.
Higher Dose of Oral Semaglutide More Effective for Patients With T2D
According to a recent study, the diabetes medication semaglutide is more effective as a 25 mg or 50 mg dose on its own, rather than a 14 mg add-on dose with other medications.
Studying the Impact of Automated Insulin Delivery on Patients With Type 1 and Type 2 Diabetes
Two posters presented at APhA in Phoenix examined the efficacy of the Omnipod® 5 Automated Insulin Delivery System.
Pharmacy Practitioners Describe Experiences With COVID-19 Misinformation
COVID-19 misinformation is common. A study presented at the annual APhA meeting examined how new pharmacy practitioners responded to misinformation and tried to minimize its spread.
Rezafungin for Injection to Treat Candidemia and Invasive Candidiasis Gets FDA Approval
The drug, branded as Rezzayo, is the first FDA-approved invasive candidiasis treatment in over a decade.
Examining The True Cost Of Diabetes Medication
About 1 in 10 individuals in the United States have diabetes. A recent study examines how much they are paying on average for access to treatment for the common disease.
How Individuals Are Self-Treating Long COVID
New research examines how individuals with continuing COVID-19 symptoms are managing the virus.
How Pharmacists Can Assist Underserved Communities After Natural Disasters
Rural communities are often left without adequate assistance in times of need, but pharmacists can provide crucial care.